Stay updated with breaking news from Diagnostics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investorideas.com , a global investor news source covering health and wellness stocks releases a special report on breakthrough technologies for mental health, featuring PanGenomic Health Inc. ....
Co-Diagnostics (NASDAQ:CODX – Free Report) had its price target upped by HC Wainwright from $2.00 to $3.00 in a report released on Monday, Benzinga reports. The firm currently has a neutral rating on the stock. HC Wainwright also issued estimates for Co-Diagnostics’ Q4 2023 earnings at ($0.20) EPS, FY2023 earnings at ($0.90) EPS, Q1 2024 […]
PanGenomic Health Inc - Vancouver, Canada-based precision health company - Says subsidiary MUJN Diagnostics Inc has launched its brain-derived neurotrophic factor or BDNF mental health biomarker...
Lucid Diagnostics Inc. (NASDAQ:LUCD – Get Free Report) was the target of a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 108,700 shares, a growth of 12.4% from the October 15th total of 96,700 shares. Approximately 1.1% of the company’s shares are short sold. […]
/PRNewswire/ -- The diagnostic electrocardiograph (ECG) market is expected to grow by USD 4.35 billion from 2023 to 2028. In addition, the momentum of the...